Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N K Man

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Bulletin De L'Academie Nationale De Medecine|May 1, 1987
[Role of halophilic and halotrophic bacteria in the chronic problems of long-term dialysis]V Goury, S Guyomard, M Mollet, et al.
Clinical Chemistry|April 1, 1983
Improved separation and quantification of the "middle molecule" b4-2 in uremiaP Faguer, N K Man, G Cueille, et al.
Artificial Organs|January 1, 1981
Technical aspects on middle molecules: separation, isolation, and identificationG Cueille, N K Man, A Sausse, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Noninvasive and invasive blood flowmetry in hemodialyzed patients with high blood flow fistulasB I Levy, P Bourquelot, J C Ponsin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factorsP Jungers, T Hannedouche, Y Itakura, et al.
Artificial Organs|May 1, 1980
Uremic neurotoxin in the middle molecular weight rangeN K Man, G Cueille, J Zingraff, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1973
An approach to "middle molecules" identification in artificial kidney dialysate, with reference to neuropathy preventionN K Man, B Terlain, J Paris, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2000
[Incidence of end-stage renal disease in Ile de France: a prospective epidemiological survey]P Jungers, Z Massy, N K Man, et al.
Kidney International. Supplement|December 1, 1976
Clinical use of oxystarchN K Man, T Drueke, A Becker, et al.
Artificial Organs|August 1, 1988
Influence of the surface area of different dialysis membranes on granulocyte adherence and superoxide generationJ L Paul, M Roch-Arveiller, E Postaire, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Bulletin De L'Academie Nationale De Medecine|May 1, 1987
[Role of halophilic and halotrophic bacteria in the chronic problems of long-term dialysis]V Goury, S Guyomard, M Mollet, et al.
Clinical Chemistry|April 1, 1983
Improved separation and quantification of the "middle molecule" b4-2 in uremiaP Faguer, N K Man, G Cueille, et al.
Artificial Organs|January 1, 1981
Technical aspects on middle molecules: separation, isolation, and identificationG Cueille, N K Man, A Sausse, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Noninvasive and invasive blood flowmetry in hemodialyzed patients with high blood flow fistulasB I Levy, P Bourquelot, J C Ponsin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factorsP Jungers, T Hannedouche, Y Itakura, et al.
Artificial Organs|May 1, 1980
Uremic neurotoxin in the middle molecular weight rangeN K Man, G Cueille, J Zingraff, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1973
An approach to "middle molecules" identification in artificial kidney dialysate, with reference to neuropathy preventionN K Man, B Terlain, J Paris, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2000
[Incidence of end-stage renal disease in Ile de France: a prospective epidemiological survey]P Jungers, Z Massy, N K Man, et al.
Kidney International. Supplement|December 1, 1976
Clinical use of oxystarchN K Man, T Drueke, A Becker, et al.
Artificial Organs|August 1, 1988
Influence of the surface area of different dialysis membranes on granulocyte adherence and superoxide generationJ L Paul, M Roch-Arveiller, E Postaire, et al.
Pageof 15